| Literature DB >> 16403436 |
Osamu Tsukamoto1, Tetsuo Minamino, Ken-ichiro Okada, Yasunori Shintani, Seiji Takashima, Hisakazu Kato, Yulin Liao, Hidetoshi Okazaki, Mitsutoshi Asai, Akio Hirata, Masashi Fujita, Yoshihiro Asano, Satoru Yamazaki, Hiroshi Asanuma, Masatsugu Hori, Masafumi Kitakaze.
Abstract
The ubiquitin-proteasome system contributes to regulation of apoptosis degrading apoptosis-regulatory proteins. Marked accumulation of ubiquitinated proteins in cardiomyocytes of human failing hearts suggested impaired ubiquitin-proteasome system in heart failure. Since cardiomyocyte apoptosis contributes to the progression of cardiac dysfunction in pressure-overloaded hearts, we investigated the role of ubiquitin-proteasome system in such conditions. We found that proteasome activities already depressed before the onset of cardiac dysfunction in pressure-overloaded hearts of mice. Cardiomyocyte apoptosis was observed along with depression of proteasome activities and elevation of proapoptotic/antiapoptotic protein ratio in failing hearts. In cultured cardiomyocytes, pharmacological inhibition of proteasome accumulated proapoptotic proteins such as p53 and Bax. Gene silencing of these proapoptotic proteins by RNA interference prevented the accumulation of respective proteins and attenuated cardiomyocyte apoptosis induced by proteasome inhibition. We conclude that depression of proteasome activities contributes to cardiac dysfunction resulting from cardiomyocyte apoptosis through accumulation of proapoptotic proteins by impaired degradation.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16403436 DOI: 10.1016/j.bbrc.2005.12.120
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575